Form 4: CoreWeave CDO Executes Pre-Planned Stock Sales

CoreWeave's Chief Development Officer, Brannin McBee, reported the conversion and sale of Class A Common Stock through two family trusts under a Rule 10b5-1 trading plan.

Summary

• Brannin McBee, Chief Development Officer of CoreWeave, Inc., reported transactions involving the company's Class A and Class B Common Stock.
• The transactions, dated January 12, 2026, were executed pursuant to a Rule 10b5-1 trading plan adopted on September 2, 2025.
• The Brannin J. McBee 2022 Irrevocable Trust converted 25,000 shares of Class B Common Stock into Class A Common Stock and subsequently sold all 25,000 Class A shares.
• The sales from the Brannin J. McBee 2022 Irrevocable Trust occurred at weighted average prices ranging from $78.5329 to $91.738 per share.
• The Canis Major 2025 Family Trust LLC converted 1,000 shares of Class B Common Stock into Class A Common Stock and subsequently sold all 1,000 Class A shares.
• The sales from the Canis Major 2025 Family Trust LLC occurred at weighted average prices ranging from $78.8378 to $91.87 per share.
• Following these transactions, the Brannin J. McBee 2022 Irrevocable Trust still beneficially owns 4,091,020 shares of Class B Common Stock.
• The Canis Major 2025 Family Trust LLC still beneficially owns 113,600 shares of Class B Common Stock.
• Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election or upon certain transfers or events.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing reports pre-planned insider stock sales under a Rule 10b5-1 plan, which are generally not indicative of new positive or negative company developments. The sales occurred at increasing prices, which is a positive for the stock's performance during the sale period, but the act of selling itself is a reduction in direct insider holdings.

Positives

• The sales were executed at progressively higher price points, indicating a rising stock value during the transaction period, with prices ranging from $77.94 to $91.87.
• The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, which suggests a structured and non-discretionary approach to stock sales, reducing concerns about opportunistic insider selling.

Negatives

• The Chief Development Officer, through related trusts, has reduced direct holdings of Class A Common Stock by 26,000 shares, which could be perceived as a slight reduction in direct insider alignment, although substantial Class B holdings remain.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding CoreWeave's future performance or strategic direction.

Industry Context

This insider transaction report is a routine disclosure and does not provide specific insights into broader industry trends or CoreWeave's competitive position. It reflects an individual executive's pre-planned stock liquidity event.

Related Party Transactions

• The reported transactions involve the Brannin J. McBee 2022 Irrevocable Trust, where the reporting person's spouse is trustee and beneficiaries include the spouse and minor child.
• The reported transactions also involve the Canis Major 2025 Family Trust LLC, where the reporting person serves as manager.

Stakeholder Impact

• Shareholders: The sale of 26,000 Class A shares by a key executive, even if pre-planned, slightly reduces direct insider ownership, which some investors may view as a minor negative. However, substantial Class B holdings remain, maintaining significant alignment.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Keywords

CoreWeave, CRWV, Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, Chief Development Officer, Class A Common Stock, Class B Common Stock, Trust Transactions